Here's how I think about both — the three areas my research and writing sit at the intersection of.
Understanding how tumors communicate with their environment — the immune cells and microbial signals inside them — and why that complexity matters for who precision medicine actually works for.
Following the path from lab discovery to priced treatment, and identifying exactly where affordability gets decided — and where it gets ignored.
Mapping where low-income families actually lose access to cancer treatment — insurance eligibility, geography, clinical trial enrollment, and beyond.
A calibrated model predicting that adaptive vemurafenib dosing could delay regrowth about 2.2 times versus continuous dosing.
How tightly lineage and fate are linked in developing cortical interneurons.
A refundable state credit to support caregivers and relieve pressure on NYC's home care system and Medicaid costs.
